Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Pancreatic Neoplasms

eicosapentaenoic acid ethyl ester has been researched along with Pancreatic Neoplasms in 1 studies

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akita, H1
Takahashi, H1
Asukai, K1
Tomokuni, A1
Wada, H1
Marukawa, S1
Yamasaki, T1
Yanagimoto, Y1
Takahashi, Y1
Sugimura, K1
Yamamoto, K1
Nishimura, J1
Yasui, M1
Omori, T1
Miyata, H1
Ochi, A1
Kagawa, A1
Soh, Y1
Taniguchi, Y1
Ohue, M1
Yano, M1
Sakon, M1

Trials

1 trial available for eicosapentaenoic acid ethyl ester and Pancreatic Neoplasms

ArticleYear
The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control study.
    Clinical nutrition ESPEN, 2019, Volume: 33

    Topics: Aged; Chemoradiotherapy; Dietary Supplements; Eicosapentaenoic Acid; Female; Humans; Male; Middle Ag

2019